Our brilliant team of scientists and engineers strives to develop transformative immunotherapeutics through innovative technologies and creative partnerships to benefit patients with unmet needs.
George Wu
CEO & Cofounder
Yonglei Shang
Interim CTO
Lei Zheng
Interim CMO & Chief Medical Advisor
Aude Segaliny
VP, Research and Early Development
Weian Zhao
Cofounder & Scientific Advisor
Philip Tagari
Ming Li
Robert Kiss
Jane Gross
Join Us
